After passing through menopause, many feel that "it's not like before," and many experience discomfort of dryness and stinging especially during intercourse. In the clinic, it is not uncommon for people to come after enduring it for years, thinking "this is just what happens with age." Postmenopausal painful sex has a relatively clear cause, and it is an area that can improve considerably when treatment options are applied stepwise in line with that cause. In this article I organize what treatment choices there are and, according to the symptom pattern, what to consider first, together with society recommendations.
Why does postmenopausal painful sex occur
The core background of postmenopausal painful sex is the change in vaginal and vulvar tissue due to the decline of the female hormone. When estrogen decreases, the vaginal mucosa thins (atrophy), and as collagen and elastic fibers decrease, lubrication drops. At the same time, the vaginal pH rises, making the mucosa easily irritated and likely to be accompanied by inflammation and stinging. The North American Menopause Society organized this series of changes appearing in the vagina, vulva, and lower urinary tract after menopause under the term genitourinary syndrome of menopause (GSM).
This syndrome is not infrequently reported in menopausal women and can affect sexual function and quality of life (North American Menopause Society, 2020). The important point is that it is not a change that gets better on its own with time. Rather, if you endure the discomfort and avoid intercourse, secondary problems may add on and the pattern can become complex.
Menopausal painful sex is an area that can improve well when the exact cause is found and treatment goes in stepwise. Rather than unconditionally enduring it, thinking "is this just how it is," we recommend checking it once.
The starting point of treatment: moisturizers and lubricants
If symptoms are mild or you are just starting treatment, the non-hormonal options of vaginal moisturizers and lubricants become the first starting point. The two have different roles. Lubricant is an immediate aid used right before intercourse to reduce pain from friction, while moisturizer is management used regularly on an everyday basis to maintain the moisture of the mucosa.
The North American Menopause Society presents non-hormonal lubricants and long-acting moisturizers as a first option when symptoms are relatively mild (North American Menopause Society, 2020). The GSM clinical guideline jointly published in 2025 by the American Urological Association and others also recommends moisturizers and lubricants, alone or in combination with other treatments, for improving vaginal dryness and painful sex (AUA·SUFU·AUGS, 2025).
However, cases where moisturizers and lubricants alone are not enough are also common. If mucosal atrophy has progressed, moisturizing alone has limits, so the next step of treatment is considered together. If you are curious about vaginal dryness itself, reading the article explaining the causes of vaginal dryness in more detail together also helps.
Local (vaginal) estrogen, the core treatment option
In postmenopausal painful sex with clear mucosal atrophy, the representative option that addresses the root cause is low-dose vaginal estrogen. Estrogen applied locally to the vagina acts in the direction of restoring the thickness of the thinned mucosa, normalizing the raised pH, and improving lubrication.
Society recommendations back this up. The North American Menopause Society presents low-dose vaginal estrogen as an effective treatment for moderate or greater GSM (North American Menopause Society, 2020), and the 2025 American Urological Association guideline also presents local low-dose vaginal estrogen for improving vaginal dryness, irritation, and painful sex (AUA·SUFU·AUGS, 2025). As non-hormonal prescription options, intravaginal DHEA (prasterone) inserts, oral ospemifene, and the like are also organized as treatment choices for moderate or greater symptoms.
However, the regimen, indications, and safety with long-term use require individual consultation. The society also mentions that data on the long-term endometrial safety of vaginal estrogen is not sufficient (NAMS, 2020), so rather than self-judgment, it is advisable to confirm suitability through a visit. If you are curious about the safe use of local estrogen, you may also refer to the article organizing points to check when using local estrogen.
If you are curious about treatment that suits your symptoms, get a consultationTreatment scenarios by symptom pattern
In the clinic, the cause of painful sex often does not come down to one thing but is compound. So even with the same diagnosis, the treatment combination differs from person to person. Organizing the patterns I often see into three is as follows.
| Pattern | Core problem | Priority option to consider |
|---|---|---|
| Dryness and pain centered | Mucosal atrophy, raised pH, stinging | Low-dose vaginal estrogen, with moisturizer and lubricant as an early aid |
| Atrophy with added laxity | Mucosal atrophy accompanied by reduced collagen and elasticity | Hormone supplementation alongside mucosa and environment care |
| Muscle tension learned from repeated pain | Pelvic floor over-tension, anticipatory pain | Pelvic floor relaxation treatment alongside hormone and moisturizing |
The first pattern is the most basic form. Centering on vaginal estrogen that restores the mucosa, moisturizers and lubricants fill in like a "bridge" the discomfort in the 2 to 6 weeks before the hormone effect emerges. If vulvar dermatitis or infection is accompanying it, treating that part first before proceeding makes recovery faster.
Atrophy with added laxity
The second pattern is where, in addition to mucosal atrophy, a decline in elasticity due to childbirth and aging is also present, making a sense of friction and reduced lubrication prominent. In this case, a combination is considered that reinforces the mucosal structure with hormones and runs vaginal environment (probiotics, pH) management alongside.
Energy-based treatments aiming at collagen regeneration (CO₂, Er:YAG laser, radiofrequency) are sometimes considered together. However, this part should be approached cautiously. The North American Menopause Society held that there are insufficient placebo-controlled studies to conclude on the efficacy and safety of energy-based treatments such as lasers (NAMS, 2020), and the 2025 American Urological Association guideline classifies use outside clinical trials as an area where evidence is not yet sufficient (AUA·SUFU·AUGS, 2025). Since there may be individual variation in effect, we recommend deciding after sufficiently discussing the indications and expectations in a visit. The overall content of non-surgical tightening options can be examined further in the article on non-surgical options for vaginal tightening.
When pain repeated and the muscle learned tension
The third pattern is where dryness and pain repeat for a long time and the pelvic floor muscles harden into an over-tense state. Upon insertion the muscle reflexively contracts, and over time anticipatory pain, the expectation that "it will probably hurt again," is added. This stage is not resolved by simple dryness treatment alone.
In this case, the approach of lowering tension and reducing reflexive contraction with pelvic floor relaxation treatment is placed at the center. At the same time, hormones restore mucosal health to reduce secondary pain from dryness, with moisturizers and lubricants as aids. The society guideline also presents referral to a pelvic floor specialist physical therapist as one option in GSM accompanied by pelvic floor dysfunction (AUA·SUFU·AUGS, 2025). Relatively quick improvement is reported when hormone and muscle treatment are run together.
Precise diagnosis comes first before treatment
Which option to choose ultimately depends on "which pattern my symptoms are close to." So even the same laser or the same hormone is applied differently from person to person. In clinical experience, skipping the diagnostic stage and deciding on a procedure first tends to lower satisfaction.
When diagnosing postmenopausal painful sex, generally the following are checked.
- Assessment of vaginal mucosal condition and degree of atrophy
- pH and vaginal environment check
- Confirmation of pelvic floor muscle tension
- Confirmation via ultrasound of any pelvic abnormality of the pelvis, uterus, ovaries, and so on
- Matching a treatment scenario according to the symptom pattern
In particular, if there is new bleeding that arose after menopause or discharge different from usual, a check is essential, separate from painful sex. This part is explained separately in the article on why post-menopause bleeding is not a period.
Do not endure it; check it once
Postmenopausal painful sex is a symptom with clear room for improvement, too much to pass off as "due to age." There are stages, from non-hormonal options like moisturizers and lubricants to low-dose vaginal estrogen and pelvic floor treatment, and combining them according to the symptom pattern is reported to reduce discomfort in many cases. However, since there is individual variation in effect and the suitable method, confirming your pattern through a visit rather than self-judgment is the first step.
Do not agonize and endure alone; come for a relaxed consultation. A female OB/GYN specialist will check your symptoms together with you. Start a painful-sex consultation by chat now.
Written by: Lee Dong-hee, Director · OB/GYN Specialist · View physician profile
First published November 22, 2025 · Last reviewed May 30, 2026
References: North American Menopause Society GSM Position Statement (2020), AUA·SUFU·AUGS Guideline on Genitourinary Syndrome of Menopause (2025)
This article is intended to provide general health information and is not a substitute for individual diagnosis or treatment. If you have symptoms, please consult through a medical visit.